Explore / Clinical trial
Clinical trial

Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine

King's College LondonCompletedEarly Phase 1Started Sep 27, 202127 enrolledUnited KingdomNCT04977674

Abstract

The overarching aim of this research is to determine the acute effects of ketamine on brain glutamate, functional connectivity and cerebral blood flow in treatment-resistant depression, explore whether the effects are attenuated by the opioid receptor antagonist naltrexone and relate these findings to antidepressant response.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

naltrexoneglutamateopioidmajor depressive disorderMDDDepressive Disorder, Treatment-Resistant

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

This study's objects

Directly linked records, matched by DOI, trial reference, or registry, not just topic.